Intra-cellular therapies announces board of director nominations in advance of 2021 annual meeting

Board of directors nominates sir michael rawlins gbe m.d., frcp, fmedsci, former chairman of the uk's medicines and healthcare products regulatory agency (mhra), as a new, independent director board of directors nominates sir michael rawlins gbe m.d., frcp, fmedsci, former chairman of the uk's medicines and healthcare products regulatory agency (mhra), as a new, independent director
ITCI Ratings Summary
ITCI Quant Ranking